
AXON · Nasdaq
The available consensus is Buy across 12 analysts, with a reported mean price target of $700. The data supplies neither a low nor a high target, so target clustering and the width of the spread cannot be established. It also does not identify the most bullish or least bullish analyst, provide named firms, or document any rating or target revisions during the past week. The substantive evidence behind the positive view is Axon's strong revenue-growth outlook, supported by demand across devices and software, plus its recurring cloud-software model and integrated ecosystem. The principal counterargument is rising cost pressure, alongside the decline in FY2025 net income to $0.1 billion from $0.4 billion in FY2024 despite higher revenue.